Sign in →

Test ID CILMF Congenital Infantile Leukemia, Specified FISH, Varies


Ordering Guidance


This test is only performed on specimens from patients with acute leukemia who are 18 months of age or younger.

 

This test is intended for instances when limited congenital infantile leukemia fluorescence in situ hybridization (FISH) probes are needed. The FISH probes to be analyzed must be specified on the request, otherwise test processing may be delayed in order to determine the intended analysis.

-If specific probes are not included with this order, the test may be canceled and automatically reordered by the laboratory as CILDF / Congenital Infantile Leukemia, Diagnostic FISH, Varies.

-If this test is ordered on a patient 19 months or older, this test will be canceled and automatically reordered by the laboratory as BALPF / B-Cell Acute Lymphoblastic Leukemia/Lymphoma (ALL), FISH, Pediatric, Varies ; TALPF / T-Cell Acute Lymphoblastic Leukemia/Lymphoma (ALL), FISH, Pediatric, Varies; or AMLPF / Acute Myeloid Leukemia (AML), FISH, Pediatric, Varies, based on patient's reason for testing.

-If this test is ordered and the laboratory is informed that the patient is on a Children's Oncology Group (COG) protocol, this test will be canceled and automatically reordered by the laboratory as COGBF / B-Cell Acute Lymphoblastic Leukemia/Lymphoma (ALL), Children's Oncology Group Enrollment Testing, FISH, Varies; COGTF / T-Cell Acute Lymphoblastic Leukemia/Lymphoma (ALL), Children's Oncology Group Enrollment Testing, FISH, Varies; or COGMF / Acute Myeloid Leukemia (AML), Children's Oncology Group Enrollment Testing, FISH, Varies based on the patient's protocol.

 

If the entire congenital infantile leukemia FISH panel is preferred, order CILDF / Congenital Infantile Leukemia, Diagnostic FISH, Varies.

 

At diagnosis, conventional cytogenetic studies (CHRBM / Chromosome Analysis, Hematologic Disorders, Bone Marrow) and a complete CILDF / Congenital Infantile Leukemia, Diagnostic FISH, Varies panel should be performed.

 

For testing paraffin embedded tissue samples from patients with congenital infantile leukemia, order CILPF / Congenital Infantile Leukemia, FISH, Tissue.



Shipping Instructions


Advise Express Mail or equivalent if not on courier service.



Necessary Information


1. A list of probes requested for analysis is required. Probes available for this test are listed in the Testing Algorithm section.

2. A reason for testing and a flow cytometry and/or a bone marrow pathology report, if available, should be submitted with each specimen. The laboratory will not reject testing if this information is not provided; however, appropriate testing and interpretation may be compromised or delayed. If not provided, an appropriate indication for testing may be entered by Mayo Clinic Laboratories.



Specimen Required


Submit only 1 of the following specimens:

 

Preferred

Specimen Type: Bone marrow

Container/Tube:

Preferred: Yellow top (ACD)

Acceptable: Green top (heparin) or lavender top (EDTA)

Specimen Volume: 2-3 mL

Collection Instructions:

1. It is preferable to send the first aspirate from the bone marrow collection.

2. Invert several times to mix bone marrow.

3. Send bone marrow specimen in original tube. Do not aliquot.

 

Acceptable

Specimen Type: Whole blood

Container/Tube:

Preferred: Yellow top (ACD)

Acceptable: Green top (heparin) or lavender top (EDTA)

Specimen Volume: 6 mL

Collection Instructions:

1. Invert several times to mix blood.

2. Send whole blood specimen in original tube. Do not aliquot.


Useful For

Detecting a neoplastic clone associated with the common chromosome abnormalities and classic rearrangements seen in infant patients with leukemia using client specified probe sets

 

An adjunct to conventional chromosome studies in infant patients with leukemia.

Reflex Tests

Test ID Reporting Name Available Separately Always Performed
CILMB Probe, Each Additional (CILMF) No, (Bill Only) No

Testing Algorithm

This test includes a charge for the probe application, analysis, and professional interpretation of results for 1 probe set (2 individual fluorescence in situ hybridization probes). Additional charges will be incurred for all reflex or additional probe sets performed.

 

If the patient is being treated for known abnormalities, indicate the abnormality and which probes should be used.

 

When specified, any of the following primary or reflex probes will be performed; reflex probes are noted with an asterisk*: Reflex probes can be added, as requested, but remain optional.

11q23 rearrangement, MLL (KMT2A)

*t(4;11)(q21;q23) AFF1/MLL

*t(6;11)(q27;q23) MLLT4(AFDN)/MLL

*t(9;11)(p22;q23) MLLT3/MLL

*t(10;11)(p12;q23) MLLT10/MLL

*t(11;19)(q23;p13.1) MLL/ELL

*t(11;19)(q23;p13.3) MLL/MLLT1

t(8;16), KAT6A/CREBBP

*D8Z2/MYC for trisomy 8

t(1;22), RBM15/MKL1

+13/+21, 13q14 and 21q22

inv(16), MYH11/CBFB

*16q22 rearrangement, CBFB break-apart

t(8;21), [M2], RUNX1T1/RUNX1

t(15;17), [M3], PML/RARA

*17q21 rearrangement, RARA break-apart

-5/5q-, D5S630/EGR1

-7/7q-, D7Z1/ D7S486

inv(3) or t(3;3), RPN1/MECOM

*3q26.2 rearrangement, MECOM break-apart

t(6;9), DEK/NUP214

12p13 rearrangement, ETV6 break-apart

*t(7;12)(q36;p13), MNX1/ETV6

inv(16), GLIS2/CBFA2T3

11p15.4 rearrangement, NUP98 break-apart

*t(7;11)(p15;p15.4), HOXA9/NUP98

+9/9p-, CDKN2A/D9Z1

t(9;22) BCR/ABL1, ABL1 amplification

*9q34 rearrangement, ABL1 break-apart

-17/17p-, TP53/D17Z1

t(1;19)(q23;p13), PBX1/TCF3

Hyperdiploidy, +4,+10,+17: D4Z1/D10Z1/D17Z1

t(12;21)(p13;q22), ETV6/RUNX1 fusion, iAMP21

*12p13 rearrangement, ETV6 break-apart

14q32 rearrangement, IGH break-apart

t(Xp22.33;var) or t(Yp11.32;var), CRLF2 rearrangement

*t(X;14)(p22.33;q32) or t(Y;14)(p11.32;q32), CRLF2/IGH

t(Xp22.33;var) or t(Yp11.32;var), P2RY8 rearrangement

8q24.1 rearrangement, MYC break-apart

1q25 rearrangement, ABL2 break-apart

5q32 rearrangement, PDGFRB break-apart

9p24.1 rearrangement, JAK2 break-apart

9q34 rearrangement, ABL1 break-apart

7p-, IKZF1/CEP7

t(5;14), TLX3/BCL11B

7q34 rearrangement, TRB break-apart

*t(6;7) - MYB/TRB fusion

*t(7;10) - TRB/TLX1

*t(7;11) - TRB/LMO1

*t(7;11) - TRB/LMO2

14q11.2 rearrangement, TRAD break-apart

*t(8;14) - MYB/TRAD

*t(10;14) - TLX1/TRAD

*t(11;14) - LMO1/TRAD

*t(11;14) - LMO2/TRAD

t(10;11), MLLT10/PICALM

1p33 rearrangement, TAL1/STIL

Method Name

Fluorescence In Situ Hybridization (FISH)

Reporting Name

Cong Infantile Leukemia, Spec FISH

Specimen Type

Varies

Specimen Minimum Volume

Blood: 2 mL
Bone Marrow: 1 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Varies Ambient (preferred)
  Refrigerated 

Reference Values

An interpretive report will be provided.

Day(s) Performed

Monday through Friday

Report Available

7 to 10 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test was developed, and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.

CPT Code Information

88271 x2, 88275 x1, 88291 x1-FISH Probe, Analysis, Interpretation; 1 probe set

88271 x2, 88275 x1-FISH Probe, Analysis; each additional probe set (if appropriate)

LOINC Code Information

Test ID Test Order Name Order LOINC Value
CILMF Cong Infantile Leukemia, Spec FISH In Process

 

Result ID Test Result Name Result LOINC Value
614241 Result Summary 50397-9
614242 Interpretation 69965-2
614243 Result Table 93356-4
614244 Result 62356-1
GC109 Reason for Referral 42349-1
GC110 Probes Requested 78040-3
GC111 Specimen 31208-2
614245 Source 31208-2
614246 Method 85069-3
614247 Additional Information 48767-8
614248 Disclaimer 62364-5
614249 Released By 18771-6